Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Prepaid Assets: 2016-2024

Historic Prepaid Assets for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $13.7 million.

  • Organogenesis Holdings' Prepaid Assets rose 48.26% to $22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.6 million, marking a year-over-year increase of 48.26%. This contributed to the annual value of $13.7 million for FY2024, which is 31.15% up from last year.
  • Organogenesis Holdings' Prepaid Assets amounted to $13.7 million in FY2024, which was up 31.15% from $10.5 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Prepaid Assets registered a high of $13.7 million during FY2024, and its lowest value of $4.9 million during FY2020.
  • Moreover, its 3-year median value for Prepaid Assets was $10.5 million (2023), whereas its average is $9.8 million.
  • Data for Organogenesis Holdings' Prepaid Assets shows a peak YoY surged of 105.54% (in 2023) over the last 5 years.
  • Organogenesis Holdings' Prepaid Assets (Yearly) stood at $4.9 million in 2020, then climbed by 0.69% to $5.0 million in 2021, then climbed by 2.35% to $5.1 million in 2022, then spiked by 105.54% to $10.5 million in 2023, then surged by 31.15% to $13.7 million in 2024.